Skip to main content
SpringerLink
Log in
Book cover

The ASCRS Textbook of Colon and Rectal Surgery pp 803–812Cite as

Colorectal Cancer: Surveillance

  • Chapter
  • First Online:

  • 3288 Accesses

Abstract

The majority of patients with colon and rectal cancer undergo curative resection and become candidates for continuing surveillance. It is well understood that the risk of colorectal cancer recurrence is largely dependent on the stage of disease at initial presentation and the appropriate level of postoperative surveillance should reflect this degree of risk stratification. Therefore, considerable effort has been devoted to the follow-up and surveillance of patients who have undergone curative-intent surgery. Continued surveillance is imperative to detect both metachronous neoplasms and prevent the development of subsequent cancers. In theory, proper surveillance allows subsequent polyps to be removed before malignant transformation occurs and improve survival by early identification of treatable recurrent cancer. Furthermore, surveillance directs family members of patients with hereditary cancers to receive proper screening and genetic counseling.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Giordano P, Efron J, Vernava 3rd AM, Weiss EG, Nogueras JJ, Wexner SD. Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol. 2006;10(3):199–207.

    Article  CAS  Google Scholar 

  2. Vernava 3rd AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1994;37(6):573–83.

    Article  Google Scholar 

  3. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol. 2003;30(3):349–60.

    Article  Google Scholar 

  4. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005;16(5):756–61.

    Article  CAS  Google Scholar 

  5. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677–83.

    Article  Google Scholar 

  6. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.

    Article  Google Scholar 

  7. Böhm B, Schwenk W, Hucke HP, Stock W. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum. 1993;36(3):280–6.

    Article  Google Scholar 

  8. Rao AR, Kagan AR, Chan PM, Gilbert HA, Nussbaum H, Hintz BL. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer. 1981;48(6):1492–5.

    Article  CAS  Google Scholar 

  9. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons Jr RJ, Pemberton JH, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992;174(1):27–32.

    CAS  PubMed  Google Scholar 

  10. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141(1):67–75.

    Article  Google Scholar 

  11. Griffin MR, Bergstralh EJ, Coffey RJ, Beart Jr RW, Melton 3rd LJ. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer. 1987;60(9):2318–24.

    Article  CAS  Google Scholar 

  12. Cho YB, Chun HK, Yun HR, Lee WS, Yun SH, Lee WY. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum. 2007;50(8):1204–10.

    Article  Google Scholar 

  13. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum. 1995;38(6):619–26.

    Article  CAS  Google Scholar 

  14. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002;28(4):418–23.

    Article  Google Scholar 

  15. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;(1):CD002200.

    Google Scholar 

  16. Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997;84(5):666–9.

    Article  CAS  Google Scholar 

  17. Mäkelä JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg. 1995;130(10):1062–7.

    Article  Google Scholar 

  18. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum. 1998;41(9):1127–33.

    Article  CAS  Google Scholar 

  19. Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, Bessa X, et al. Postoperative surveillance in patients with ­colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006;24(3):386–93.

    Article  Google Scholar 

  20. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114(1):7–14.

    Article  CAS  Google Scholar 

  21. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs. surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94(8):1116–21.

    Article  CAS  Google Scholar 

  22. Desch CE, Benson 3rd AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23(33):8512–9.

    Article  Google Scholar 

  23. Anthony T, Simmang C, Hyman N, Buie D, Kim D, Cataldo P, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47(6):807–17.

    Article  Google Scholar 

  24. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. J Natl Compr Canc Netw. 2009;7(8):778–831.http://www.nccn.org/professionals/physician_gls/f_guidelines.asp

  25. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O’Connell MJ, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006;98(22):1647–54.

    Article  Google Scholar 

  26. Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. Impact of physical activity on cancer recurrence and survival in patients with Stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24(22): 3535–41.

    Article  Google Scholar 

  27. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, et al. Association of dietary patterns with cancer recurrence and survival in patients with Stage III colon cancer. JAMA. 2007;298(7):754–64.

    Article  CAS  Google Scholar 

  28. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 2005;23(4):338–51.

    Article  Google Scholar 

  29. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YK, Euk W. High preoperative serum CEA predicts metastatic recurrence in potentially curable colon cancer. Dis Colon Rectum. 2001;44(2):231–5.

    Article  CAS  Google Scholar 

  30. Slentz K, Senagore AJ, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg. 1994;60(7):528–32.

    CAS  PubMed  Google Scholar 

  31. Martin EW, Minton JP, Carey LC. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann Surg. 1983;202:310–7.

    Article  Google Scholar 

  32. Allen-Mersh TG. Aspects of treatment. Serum CEA in the follow-up of colorectal carcinoma. Experience in a district general hospital. Ann R Coll Surg Eng. 1984;66:751–5.

    Google Scholar 

  33. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 1994;37:875–81.

    Article  CAS  Google Scholar 

  34. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Lauri JA, Tangen CM. An evaluation of the carcinoembryonic antigen test for monitoring patients with resected colon cancer. JAMA. 1993;270:943–7.

    Article  CAS  Google Scholar 

  35. Carriquiry L, Pineyro A. Should CEA be used in the management of patients with colorectal cancer? Dis Colon Rectum. 1999;42(7):921–9.

    Article  CAS  Google Scholar 

  36. Figuerado A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.

    Article  Google Scholar 

  37. Fazio VW, Church JM, Delaney CP. Current therapy in colon and rectal surgery. 2nd ed. Philadelphia: Elsevier Mosby Publishing; 2005. Chapter 67, Page 405.

    Google Scholar 

  38. Tsikitis VL, Malireddy K, Green EA, Christensen B, Whelan R, Hyder J, et al. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;27(22):3671–6.

    Article  Google Scholar 

  39. Abir F, Alva S, Longo WE, Audiso R, Virgo KS, Johnson FE. The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg. 2006;192(1):100–8.

    Article  Google Scholar 

  40. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg. 1998;228(1):59–63.

    Article  CAS  Google Scholar 

  41. Chau I, Allen MJ, Cunningham D, Norman AR, Brown G, Ford HE, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the ­surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol. 2004;22(8):1420–9.

    Article  CAS  Google Scholar 

  42. Schwartz RW, McKenzie S. Update on postoperative colorectal cancer surveillance. Curr Surg. 2005;62(5):491–4.

    Article  Google Scholar 

  43. Yedibela S, Klein P, Feuchter K, Hoffmann M, Meyer T, Papadopoulos T, et al. Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol. 2006;13(11):1538–44.

    Article  Google Scholar 

  44. Rena O, Casadio C, Viano F, Cristofori R, Ruffini E, Filosso PL, et al. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur J Cardiothorac Surg. 2002;21(5):906–12.

    Article  Google Scholar 

  45. Watanabe K, Nagai K, Kobayashi A, Sugito M, Saito N. ­Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg. 2009;96(9):1058–65.

    Article  CAS  Google Scholar 

  46. Park JS, Kim HK, Choi YS, Kim K, Shim YM, Jo J, et al. Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer. Ann Oncol. 2010;21(6): 1285–9.

    Article  CAS  Google Scholar 

  47. Longo WE, Johnson FE. The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am. 2002;82(5):1091–108.

    Article  Google Scholar 

  48. Bleeker WA, Mulder NH, Hermans J, Otter R, Plukker JT. Value and cost of follow-up after adjuvant treatment of patients with Dukes’ C colonic cancer. Br J Surg. 2001;88(1):101–6.

    Article  CAS  Google Scholar 

  49. Deveney KE, Way LW. Follow-up of patients with colorectal cancer. Am J Surg. 1984;148(6):717–22.

    Article  CAS  Google Scholar 

  50. Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26.

    Article  Google Scholar 

  51. Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg. 1984;147(3):330–3.

    Article  CAS  Google Scholar 

  52. Piñol V, Andreu M, Castells A, Payá A, Bessa X, Jover R, et al. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum. 2004;47(7):1192–200.

    Article  Google Scholar 

  53. Chen F, Stuart M. Colonoscopic follow-up of colorectal carcinoma. Dis Colon Rectum. 1994;37(6):568–72.

    Article  CAS  Google Scholar 

  54. Ballesté B, Bessa X, Piñol V, Castellví-Bel S, Castells A, Alenda C, et al. Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors. Dis Colon Rectum. 2007;50(7):971–80.

    Article  Google Scholar 

  55. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006;130(6):1865–71.

    Article  Google Scholar 

  56. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, ­Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and ­success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998;129(1):27–35.

    Article  CAS  Google Scholar 

  57. Rajaratnam SG, Dennett ER. Development of metachronous neoplasms after colorectal cancer resection: absence of synchronous neoplasms predicts a lower risk. N Z Med J. 2009;122(1294):61–6.

    PubMed  Google Scholar 

  58. Hyman N, Moore J, Cataldo P, Osler T. The high yield of 1-year colonoscopy after resection: is it the handoff? Surg Endosc. 2010;24(3):648–52.

    Article  Google Scholar 

  59. Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P, et al. Miss rate for colorectal neoplastic polyps: a ­prospective multicenter study of back-to-back video colonoscopies. Endoscopy. 2008;40(4):284–90.

    Article  CAS  Google Scholar 

  60. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum. 1997;40(1):15–24.

    Article  CAS  Google Scholar 

  61. Harris GJ, Church JM, Senagore AJ, Lavery IC, Hull TL, Strong SA, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029–34.

    Article  CAS  Google Scholar 

  62. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341(8843):457–60.

    Article  CAS  Google Scholar 

  63. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303–12.

    Article  Google Scholar 

  64. Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer Group. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009;96(11):1348–57.

    Article  CAS  Google Scholar 

  65. Kim NK, Kim YW, Min BS, Lee KY, Sohn SK, Cho CH. ­Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer. World J Surg. 2009;33(8):1741–9.

    Article  Google Scholar 

  66. Romano G, Esercizio L, Santangelo M, Vallone G, Santangelo ML. Impact of computed tomography vs. intrarectal ultrasound on the diagnosis, resectability, and prognosis of locally recurrent rectal cancer. Dis Colon Rectum. 1993;36(3):261–5.

    Article  CAS  Google Scholar 

  67. de Anda EH, Lee SH, Finne CO, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Endorectal ultrasound in the follow-up of rectal cancer patients treated by local excision or radical surgery. Dis Colon Rectum. 2004;47(6):818–24.

    Article  Google Scholar 

  68. Shen YY, Liang JA, Chen YK, Tsai CY, Kao CH. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen in Taiwan. Hepatogastroenterology. 2006;53(69):348–50.

    PubMed  Google Scholar 

  69. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps M, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med. 2000;41:1177–89.

    CAS  PubMed  Google Scholar 

  70. Sobhani I, Tiret E, Lebtahi R, Aparicio T, Itti E, Montravers F, et al. Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer. 2008;98:875–80.

    Article  CAS  Google Scholar 

  71. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol. 1999;34(5):509–15.

    Article  CAS  Google Scholar 

  72. Stiggelbout AM, de Haes JCJM, Vree R, van de Velde CJH, Bruijninckx CMA, van Groninger K, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997;75(6):914–20.

    Article  CAS  Google Scholar 

  73. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995;273(23):1837–41.

    Article  CAS  Google Scholar 

  74. Renehan AG, O’Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after ­curative resection for colorectal cancer. BMJ. 2004; 328(7431):81.

    Article  Google Scholar 

  75. Borie F, Combescure C, Daures JP, Tretarre B, Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg. 2004;28(6):563–9.

    Article  Google Scholar 

  76. Tjandra JJ, Chan MKY. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50: 1783–99.

    Article  Google Scholar 

  77. Ohlsson B, Pålsson B. Follow-up after colorectal cancer ­surgery. Acta Oncol. 2003;42(8):816–26.

    Article  Google Scholar 

  78. Gan S, Wilson K, Hollington P. Surveillance of patients following surgery with curative intent for colorectal cancer. World J Gastroenterol. 2007;13(28):3816–23.

    Article  Google Scholar 

  79. Pfister DG, Benson 3rd AB, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med. 2004;350(23):2375–82.

    Article  CAS  Google Scholar 

  80. Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ. 2002;324(7341):813.

    Article  Google Scholar 

Download references

Acknowledgments.

This chapter was authored by Brett T. Gemlo and David A. Rothenberger in the previous version of this textbook.

Author information

Authors and Affiliations

  1. Ferguson Clinic, Spectrum Health Medical Group, Michigan State University, 4100 Lake Drive #205, Grand Rapids, MI, 49546, USA

    Nadav Dujovny MD

  2. Section of Colorectal Surgery, Department of Surgery, University of Kentucky, 800 Rose Street, C220, Lexington, KY, 40536, USA

    Jon S. Hourigan MD

Authors
  1. Nadav Dujovny MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jon S. Hourigan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Colon and Rectal Surgery, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA

    David E. Beck MD, FACS, FASCRS

  2. Department of Colorectal Surgery, Lahey Clinic, Tufts University School of Medicine, Burlington, Massachusetts, USA

    Patricia L. Roberts MD, FACS, FASCRS

  3. Section of Colon and Rectal Surgery, Rush Medical Center, Chicago, Illinois, USA

    Theodore J. Saclarides MD, FACS, FASCRS

  4. Department of Surgery, Spectrum Health, Grand Rapids, Michigan, USA

    Anthony J. Senagore MD, FACS, FASCRS

  5. Department of Surgery, UCI Medical Center, Orange, California, USA

    Michael J. Stamos MD, FACS, FASCRS

  6. Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, Florida, USA

    Steven D. Wexner MD, FACS, FASCRS, FRCS, FRCS(Ed)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 ASCRS (American Society of Colon and Rectal Surgeons)

About this chapter

Cite this chapter

Dujovny, N., Hourigan, J.S. (2011). Colorectal Cancer: Surveillance. In: Beck, D.E., Roberts, P.L., Saclarides, T.J., Senagore, A.J., Stamos, M.J., Wexner, S.D. (eds) The ASCRS Textbook of Colon and Rectal Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1584-9_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1584-9_48

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1581-8

  • Online ISBN: 978-1-4419-1584-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation